Syringe vs. pen: which delivers the drug better?
NCT ID NCT07413913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a pre-filled syringe and a pre-filled pen deliver the same amount of survodutide into the body. Fifty-six healthy or overweight adults received a single dose of each version in random order. Researchers measured drug levels in the blood to see if the two methods are equivalent.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Survodutide (BI 456906)
- What this could lead to
- If successful, this could confirm that the pre-filled pen delivers the drug as effectively as the syringe, making it easier for patients to use.
- What could go wrong
- This is an early-phase study focused on drug absorption, not on weight loss or health outcomes. It does not test whether survodutide works for obesity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Can a Two-Drug combo tip the scales against obesity?